Detalhe da pesquisa
1.
Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient care.
Nephrol Dial Transplant
; 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253386
2.
Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia.
BMC Nephrol
; 24(1): 18, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36658531
3.
Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden.
BMC Nephrol
; 23(1): 281, 2022 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953778
4.
Evaluation of the National Institute for Health and Care Excellence Diagnostics Assessment Program Decisions: Incremental Cost-Effectiveness Ratio Thresholds and Decision-Modifying Factors.
Value Health
; 23(10): 1300-1306, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33032773
5.
Immunomodulatory roles of selenium nanoparticles: Novel arts for potential immunotherapy strategy development.
Front Immunol
; 13: 956181, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35958612